View all cases
UPC APP 11372/2025
EP2401365 · REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION
- Case details
- Status—ActionProcedural applicationCategoryCase management orders
- Parties
- Respondents
- BioNTech SEOperating co.
- BioNTech Manufacturing GmbHOperating co.
- BioNTech Manufacturing Marburg GmbHOperating co.
- BioNTech Innovative Manufacturing Services GmbHOperating co.
- BioNTech Europe GmbHOperating co.
- Pfizer Manufacturing Belgium NVOperating co.
- Pfizer SASOperating co.
- Pfizer ABOperating co.
- Pfizer Inc.Operating co.
Representatives- Christine Kanz-Hoyng Rokh Monegier
- Tobias J. Hessel-Clifford Chance Partnerschaft mbB
- Division
- Munich LD
- Judges
- Technology
- ChemistryBiotechnology
- Language
- —
- First decided
- Apr 3, 2025
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Munich LD | Locked |
| Judge András Kupecz | Locked |
At the UPC: Promosome LLC (15 cases)·BioNTech Group (21 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 14 other proceedings
UPC CoA 146/2026·UPC CoA 147/2026·UPC CoA 148/2026·UPC CFI 2819/2026·UPC CFI 2821/2026 and 9 more
Decisions
- 2025-04-03Procedural OrderPublic
Summary: Munich Local Division order on BioNTech/Pfizer's application under R. 190 RoP for production of detailed materials, methods and raw data underlying an expert report (Exhibit VB 6) submitted by Promosome LLC (claimant) in mRNA patent infringement proceedings. The order addresses what supporting data must be disclosed when an expert report is filed as evidence.
Show the legal issues (3)
- Production of evidence (R. 190 RoP)
- Expert report materials and raw data disclosure
- mRNA technology patent infringement
Documents
- D594C630588987BAD4B3DFA685E7EFF1_en.pdf2025-04-03EN